Literature DB >> 23031251

Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice.

Younghyurk Lee1, Hyeonwi Son, Gyeongwha Kim, Sujeong Kim, Dong Hoon Lee, Gu Seob Roh, Sang Soo Kang, Gyeong Jae Cho, Wan Sung Choi, Hyun Joon Kim.   

Abstract

BACKGROUND: The brain levels of glutamate (Glu) and glutamine (Gln) are partially regulated through the Glu-Gln cycle. Astrocytes play a role in regulating the Glu-Gln cycle, and loss of astrocytes has been associated with depressive disorders. We hypothesized that levels of Glu and Gln would be affected by astrocyte loss and dysregulation of the Glu-Gln cycle and that depressive-like behaviours would be closely related to the level of changes in Glu and Gln.
METHODS: We used liquid chromatography to measure Glu and Gln concentrations in the prefrontal cortex of male mice infused with L-α aminoadipic acid (L-AAA), a specific astrocyte toxin, in the prelimbic cortex. Methionine sulfoximine, a Gln synthetase inhibitor, and α-methyl-amino-isobutyric acid, a blocker of neuronal Gln transporters, were used to disturb the Glu-Gln cycle. We assessed the behavioural change by drug infusion using the forced swim test (FST) and sucrose preference test.
RESULTS: The Glu and Gln levels were decreased on the fifth day after L-AAA infusion, and the infused mice showed longer durations of immobility in the FST and lower sucrose preference, indicative of depressive-like behaviour. Mice in which Gln synthetase or Gln transport were inhibited also exhibited increased immobility in the FST. Direct infusion of L-Gln reversed the increased immobility induced by astrocyte ablation and Glu-Gln cycle impairments. LIMITATIONS: Genetically modified animal models and diverse behavioural assessments would have been helpful to solidify our conclusions.
CONCLUSION: Neuronal Gln deficiency in the prefrontal cortex may cause depressive behaviours.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23031251      PMCID: PMC3633711          DOI: 10.1503/jpn.120024

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  53 in total

Review 1.  Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment.

Authors:  Mounira Banasr; Ronald S Duman
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-10       Impact factor: 4.388

2.  Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study.

Authors:  T R Ziegler; L S Young; K Benfell; M Scheltinga; K Hortos; R Bye; F D Morrow; D O Jacobs; R J Smith; J H Antin
Journal:  Ann Intern Med       Date:  1992-05-15       Impact factor: 25.391

3.  Reduced volume of orbitofrontal cortex in major depression.

Authors:  J Douglas Bremner; Meena Vythilingam; Eric Vermetten; Ahsan Nazeer; Jahangir Adil; Sarfraz Khan; Lawrence H Staib; Dennis S Charney
Journal:  Biol Psychiatry       Date:  2002-02-15       Impact factor: 13.382

4.  Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

Authors:  B Moghaddam; B Adams; A Verma; D Daly
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

5.  Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery.

Authors:  P Stehle; J Zander; N Mertes; S Albers; C Puchstein; P Lawin; P Fürst
Journal:  Lancet       Date:  1989-02-04       Impact factor: 79.321

6.  Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression.

Authors:  P V Choudary; M Molnar; S J Evans; H Tomita; J Z Li; M P Vawter; R M Myers; W E Bunney; H Akil; S J Watson; E G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

7.  Patients receiving glutamine-supplemented intravenous feedings report an improvement in mood.

Authors:  L S Young; R Bye; M Scheltinga; T R Ziegler; D O Jacobs; D W Wilmore
Journal:  JPEN J Parenter Enteral Nutr       Date:  1993 Sep-Oct       Impact factor: 4.016

Review 8.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

9.  Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.

Authors:  Mounira Banasr; Gerald W Valentine; Xiao-Yuan Li; Shannon L Gourley; Jane R Taylor; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2007-06-21       Impact factor: 13.382

10.  The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.

Authors:  Martin Walter; Anke Henning; Simone Grimm; Rolf F Schulte; Johannes Beck; Ulrike Dydak; Betina Schnepf; Heinz Boeker; Peter Boesiger; Georg Northoff
Journal:  Arch Gen Psychiatry       Date:  2009-05
View more
  25 in total

1.  Astrocyte pathology in the prefrontal cortex impairs the cognitive function of rats.

Authors:  A Lima; V M Sardinha; A F Oliveira; M Reis; C Mota; M A Silva; F Marques; J J Cerqueira; L Pinto; N Sousa; J F Oliveira
Journal:  Mol Psychiatry       Date:  2014-01-14       Impact factor: 15.992

Review 2.  The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology.

Authors:  Emily L Belleau; Michael T Treadway; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2018-10-10       Impact factor: 13.382

3.  In Silico Preliminary Association of Ammonia Metabolism Genes GLS, CPS1, and GLUL with Risk of Alzheimer's Disease, Major Depressive Disorder, and Type 2 Diabetes.

Authors:  Jeddidiah W D Griffin; Ying Liu; Patrick C Bradshaw; Kesheng Wang
Journal:  J Mol Neurosci       Date:  2018-02-13       Impact factor: 3.444

Review 4.  Astrocyte regulation of synaptic signaling in psychiatric disorders.

Authors:  Anna Kruyer; Peter W Kalivas; Michael D Scofield
Journal:  Neuropsychopharmacology       Date:  2022-05-16       Impact factor: 7.853

5.  Antidepressant effects of cherry leaf decoction on a chronic unpredictable mild stress rat model based on the Glu/GABA-Gln metabolic loop.

Authors:  Chuan Jiang; Hua Wang; Jiaying Qi; Jinghan Li; Qianqian He; Chaonan Wang; Yonggang Gao
Journal:  Metab Brain Dis       Date:  2022-10-01       Impact factor: 3.655

Review 6.  Control of complex behavior by astrocytes and microglia.

Authors:  P I Ortinski; K J Reissner; J Turner; T A Anderson; A Scimemi
Journal:  Neurosci Biobehav Rev       Date:  2022-04-01       Impact factor: 9.052

7.  Structural and biochemical imaging reveals systemic LPS-induced changes in the rat brain.

Authors:  Michael Fritz; Anna M Klawonn; Qingyu Zhao; Edith V Sullivan; Natalie M Zahr; Adolf Pfefferbaum
Journal:  J Neuroimmunol       Date:  2020-08-26       Impact factor: 3.478

8.  Effects of site-specific infusions of methionine sulfoximine on the temporal progression of seizures in a rat model of mesial temporal lobe epilepsy.

Authors:  Roni Dhaher; Helen Wang; Shaun E Gruenbaum; Nathan Tu; Tih-Shih W Lee; Hitten P Zaveri; Tore Eid
Journal:  Epilepsy Res       Date:  2015-05-19       Impact factor: 3.045

Review 9.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

Authors:  Grazyna Rajkowska; Craig A Stockmeier
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

Review 10.  Chronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.

Authors:  Leif Hertz; Douglas L Rothman; Baoman Li; Liang Peng
Journal:  Front Behav Neurosci       Date:  2015-02-20       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.